This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schwartz, S. M. Articles by Yuan, C. Search for Related Content PubMed PubMed Citation Articles by Schwartz, S. M. Articles by Yuan, C.

(Circulation Research. 2001;89:471.)
© 2001 American Heart Association, Inc.

Editorial

Molecular Markers, Fibrous Cap Rupture, and the Vulnerable Plaque

New Experimental Opportunities

Stephen M. Schwartz, Thomas S. Hatsukami, Chun Yuan

From the Department of Pathology, University of Washington, Seattle, Wash.

Correspondence to Stephen M. Schwartz, Department of Pathology, University of Washington, Box 35-7335, 1959 NE Pacific St, Seattle, WA 98195-7335. E-mail tamid@u.washington.edu

Key Words: KW arrays • PCR select • MRI • atherosclerosis • plaque rupture

The study by Faber et al¹ in this issue of Circulation Research uses subtraction suppression hybridization (SSH) to identify genes specific to the ruptured atherosclerotic plaque. This article may represent the early days in the oncoming studies of advanced atherosclerosis, a surprisingly neglected area of study.

Part of the reason for this neglect has been the confusion in the past several years over the term "vulnerable plaques"—lesions of atherosclerosis that are thought to be associated with a higher risk for thromboembolic complications. The American Heart Association (AHA), unfortunately, has encouraged the application of this term to a specific morphology.² The problem is that the AHA classifications scheme implies that we can define critical early and "vulnerable" lesions based on morphology observed at autopsy. Virmani et al³ have offered a simpler, less dogmatic scheme that uses morphological terms without implying mechanism. As that article discusses, a purely descriptive, nonjudgmental approach leads to more focused questions about the specific processes and related morphologies that could be hypotheses for further study. Testing those hypotheses, as we will discuss, may now be possible depending on very new methods that permit noninvasive imaging of the evolving lesions.

Faber et al,¹ although using the AHA scheme, do a very good job of specifying the morphology of their lesions. In essence, the ruptured lesions they describe have thin fibrous caps, multiple areas of disruption of that cap, and evidence of acute rupture leading to thrombosis. Lesions with similar characteristics, lacking frank rupture, are the sort called types . . . [Full Text of this Article]

This article has been cited by other articles:

				Z. S. Galis and J. J. Khatri Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: The Good, the Bad, and the Ugly Circ. Res., February 22, 2002; 90(3): 251 - 262. [Abstract] [Full Text] [PDF]